Cell and Gene Therapy Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
MARKET INTRODUCTION
Gene and cell therapy uses genes and cells for the treatment of genetic diseases. Genetic diseases are caused by mutations, or errors in genes which can be passed down from one generation to another. Gene therapy aims to treat diseases by using genetic material, or DNA, to manipulate a patient's cells by replacing, changing or introducing genome into cells- either internally or externally. Cell therapy aims to treat diseases by introducing cells into a patient's body or by using cells to carry a therapy through the body. Cells are cultured or altered outside the patient's body before being injected into the patient.
MARKET DYNAMICS
The increasing incidences of several chronic diseases, cardiovascular and neurological diseases across the globe is supposed to drive the development of the cell and gene therapy market. The rising number of clinical trials and increase in funding's and investments in this market are expected to surge the market. Furthermore, the improved healthcare facilities in developed countries are also going to increase the market growth, whereas, lack of reliable vector production, complex manufacturing and distribution layout and excessive costs of treatment method may serve as market constraints for the cell and gene therapy market.
MARKET SCOPE
The "Cell and gene therapy market analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of cell and gene therapy market with detailed market segmentation by type, application and end users. The cell and gene therapy market are expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in cell and gene therapy market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The cell and gene therapy market are segmented on the basis of type, application and end users. On the basis of type, the market is segmented into cell therapy and gene therapy. On the basis of application, the market is segmented as oncology, dermatology, musculoskeletal, genetic disorders and others. On the basis of end users, the market is segmented as hospital and clinics and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the cell and gene therapy market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The cell and gene therapy market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting cell and gene therapy market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the cell and gene therapy market in these regions.
By Type
By Application
By End- Users
MARKET PLAYERS
The report covers key developments in the cell and gene therapy market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from cell and gene therapy market are anticipated to have lucrative growth opportunities in the future with the rising demand for cell and gene therapy in the global market. Below mentioned is the list of few companies engaged in the cell and gene therapy market.
The report also includes the profiles of key players in cell and gene therapy market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Gene and cell therapy uses genes and cells for the treatment of genetic diseases. Genetic diseases are caused by mutations, or errors in genes which can be passed down from one generation to another. Gene therapy aims to treat diseases by using genetic material, or DNA, to manipulate a patient's cells by replacing, changing or introducing genome into cells- either internally or externally. Cell therapy aims to treat diseases by introducing cells into a patient's body or by using cells to carry a therapy through the body. Cells are cultured or altered outside the patient's body before being injected into the patient.
MARKET DYNAMICS
The increasing incidences of several chronic diseases, cardiovascular and neurological diseases across the globe is supposed to drive the development of the cell and gene therapy market. The rising number of clinical trials and increase in funding's and investments in this market are expected to surge the market. Furthermore, the improved healthcare facilities in developed countries are also going to increase the market growth, whereas, lack of reliable vector production, complex manufacturing and distribution layout and excessive costs of treatment method may serve as market constraints for the cell and gene therapy market.
MARKET SCOPE
The "Cell and gene therapy market analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of cell and gene therapy market with detailed market segmentation by type, application and end users. The cell and gene therapy market are expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in cell and gene therapy market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The cell and gene therapy market are segmented on the basis of type, application and end users. On the basis of type, the market is segmented into cell therapy and gene therapy. On the basis of application, the market is segmented as oncology, dermatology, musculoskeletal, genetic disorders and others. On the basis of end users, the market is segmented as hospital and clinics and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the cell and gene therapy market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The cell and gene therapy market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting cell and gene therapy market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the cell and gene therapy market in these regions.
Cell and Gene Therapy Market Report Analysis
Cell and Gene Therapy Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX Million -
Market Size 2031
US$ XX Million
![](https://www.theinsightpartners.com/assets/images/rd_int_img/tip-logo.jpg)
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Gilead Sciences
- Bristol-Myers Squibb
- Novartis AG
- Spark Therapeutics
- Amgen
- Merck
- Biogen
- Pfizer
- Dendreon
Regional Overview
![](https://www.theinsightpartners.com/assets/images/rd_int_img/ig-regional.png)
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
![](https://www.theinsightpartners.com/assets/images/rd_int_img/cust_bullet_danger.png)
- Cell Therapy
- Gene Therapy
![](https://www.theinsightpartners.com/assets/images/rd_int_img/cust_bullet_warning.png)
- Oncology
- Dermatology
- Musculoskeletal
- Genetic Disorders
- Others
![](https://www.theinsightpartners.com/assets/images/rd_int_img/cust_bullet_primary.png)
- Hospital
- Clinics
- Others
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
The report covers key developments in the cell and gene therapy market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from cell and gene therapy market are anticipated to have lucrative growth opportunities in the future with the rising demand for cell and gene therapy in the global market. Below mentioned is the list of few companies engaged in the cell and gene therapy market.
The report also includes the profiles of key players in cell and gene therapy market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Gilead Sciences.
- Bristol-Myers Squibb.
- Novartis AG.
- Spark Therapeutics.
- Amgen.
- Merck.
- Biogen.
- Pfizer.
- Dendreon.
- Vericel.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Cell and Gene Therapy Market Report Scope
Report Attribute | Details |
---|---|
Market size in 2023 | US$ XX Million |
Market Size by 2031 | US$ XX Million |
Global CAGR (2023 - 2031) | XX% |
Historical Data | 2021-2022 |
Forecast period | 2024-2031 |
Segments Covered |
By Type
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
![Report Coverage](https://www.theinsightpartners.com/assets/rdimages/report_coverage.png)
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
![Segment Covered](https://www.theinsightpartners.com/assets/rdimages/segment_covered.png)
Segment Covered
This text is related
to segments covered.
![Regional Scope](https://www.theinsightpartners.com/assets/rdimages/regional_scope.png)
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
![Country Scope](https://www.theinsightpartners.com/assets/rdimages/country_scope.png)
Country Scope
This text is related
to country scope.
The List of Companies
1. Gilead Sciences
2. Bristol-Myers Squibb
3. Novartis AG
4. Spark Therapeutics
5. Amgen
6. Merck
7. Biogen
8. Pfizer
9. Dendreon
10. Vericel
1. Gilead Sciences
2. Bristol-Myers Squibb
3. Novartis AG
4. Spark Therapeutics
5. Amgen
6. Merck
7. Biogen
8. Pfizer
9. Dendreon
10. Vericel